Verition Fund Management LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $125,710 - $308,568	-2,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $149,136 - $322,660	2,600 New	2,600 $322,000
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $1.02 Million - $1.5 Million	-11,900 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$88.49 - $127.55 $221,225 - $318,875	2,500 Added 26.6%	11,900 $1.5 Million
Q2 2018 Aug 15, 2018	BUY	$60.0 - $85.67 $564,000 - $805,298	9,400 New	9,400 $789,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.